SMS Co., Ltd. (TYO:2175)
Japan · Delayed Price · Currency is JPY 1,606.00
+12.00 (0.75%)
Sep 12, 2025, 3:30 PM JST
SMS Co., Ltd. Revenue
SMS Co., Ltd. had revenue of 18.67B JPY in the quarter ending June 30, 2025, with 7.15% growth. This brings the company's revenue in the last twelve months to 62.20B, up 10.66% year-over-year. In the fiscal year ending March 31, 2025, SMS Co., Ltd. had annual revenue of 60.95B with 12.93% growth.
Revenue (ttm)
62.20B
Revenue Growth
+10.66%
P/S Ratio
2.12
Revenue / Employee
13.74M
Employees
4,528
Market Cap
131.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 60.95B | 6.98B | 12.93% |
| Mar 31, 2024 | 53.97B | 8.31B | 18.19% |
| Mar 31, 2023 | 45.67B | 6.77B | 17.40% |
| Mar 31, 2022 | 38.90B | 2.94B | 8.17% |
| Mar 31, 2021 | 35.96B | 820.00M | 2.33% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| HOYA Corporation | 876.09B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |